Clinical Trial Detail

NCT ID NCT01802320
Title Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

colorectal adenocarcinoma

Therapies

MK2206

Age Groups: adult

Additional content available in CKB BOOST